INS and type 2 diabetes mellitus: In the treatment of type-2 diabetes, FFA4 ligands have attracted considerable interest because of their ability to enhance glucose-dependent insulin production from pancreatic β-cells as well as their anti-inflammatory actions in adipocytes and the gut [85] (Table 1).